AERIAL®: Changes in Health and Functional Status in Patients With COPD During Therapy With Spiolto® Respimat®
Phase of Trial: Phase IV
Latest Information Update: 25 Jul 2018
At a glance
- Drugs Olodaterol/tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms AERIAL
- Sponsors Boehringer Ingelheim
- 17 Apr 2018 Planned primary completion date changed from 15 May 2018 to 18 Jan 2019.
- 27 Mar 2018 Planned End Date changed from 15 May 2018 to 18 Jan 2019.
- 20 Jun 2017 Status changed from not yet recruiting to recruiting.